All articles
Can You Leave a Clinical Trial Early? Your Rights and What Happens Next
Study Basics
Published October 13, 2026 7 min read

Can You Leave a Clinical Trial Early? Your Rights and What Happens Next

You can leave a research study at any time, for any reason. Here is what withdrawing actually involves, how it can affect compensation and your data, and how to leave safely.

Written and reviewed by StudyPaid Editorial Team · Last updated October 13, 2026

Signing a consent form can feel like making a promise. It is natural to wonder: *What if I change my mind? What if the study becomes too much, my schedule changes, or I just do not feel right about it anymore?*

The short answer is reassuring. Taking part in research is voluntary from start to finish. You can leave a study at any time, for any reason — and you do not have to explain why.

Here is what that right means in practice, and how to leave in a way that protects your health.

Your right to withdraw

In the United States, federal rules that protect research participants require that the consent process explain that participation is voluntary and that you may stop at any time. Leaving should not cost you any benefits you are otherwise entitled to — for example, you cannot be denied regular medical care at a hospital because you left a study run there.

You should also never be pressured, guilted, or threatened into staying. A study team may ask why you are leaving, because your answer can help them improve the study or check on your safety, but you are not required to give a reason.

Common reasons people leave include:

  • Side effects or symptoms that feel unmanageable
  • A new job, move, or schedule change
  • Family or caregiving responsibilities
  • Feeling that the visits or procedures are more demanding than expected
  • Losing interest or simply changing your mind
  • A new diagnosis or a decision to try a different treatment with your doctor

All of these are valid.

Talk to the study team before you stop

Although you can leave at any time, the safest way to do it is to tell the study team *before* you stop taking a study medication or skip visits.

This matters because:

  • Some medications should not be stopped suddenly. Certain drugs need to be reduced gradually to avoid withdrawal effects or a return of symptoms.
  • The team may want to check your health. Many studies ask departing participants to complete a final safety visit, sometimes called an "early termination" or "end of study" visit. This can include a quick exam, blood work, or questions about how you feel. These visits are usually optional, but they help make sure you leave the study in good health.
  • Study devices or supplies may need to be returned. If you were given a device, diary, or remaining medication, the team will explain what to do with it.
  • Your care may need to be handed back to your doctor. If the study managed part of your treatment, the team can help coordinate the transition so there are no gaps.

A simple phone call or email is enough to start the process. You can say, "I've decided to leave the study. What do I need to do?"

What happens to your data?

This is one of the most common questions — and the answer may surprise you.

In many studies, the information collected *before* you withdraw can still be used. U.S. Food and Drug Administration (FDA) guidance generally allows data already gathered in a drug or device trial to be kept, because removing it could make the study's safety and effectiveness results less reliable.

What usually changes when you withdraw is that the team stops collecting *new* information from you. Some studies also ask whether they may keep checking on your health through medical records or a phone call later. You can say yes or no to that request.

Stored samples, such as blood or tissue, may be handled differently. Some studies will destroy your samples if you ask; others may keep samples that have already been made anonymous. Your consent form should explain the rules for your study. If it is unclear, ask: "If I leave, what happens to my data and samples?"

How withdrawing affects compensation

If a study offers payment, leaving early typically affects only the visits you have not completed yet. FDA guidance for researchers says payment should generally build up as the study goes along, rather than being paid only if you finish. In practice, many studies pay per visit or on a schedule, so you keep what you have already earned.

Some studies include a modest bonus for completing the full study. This is allowed as long as it is not so large that it pressures people to stay when they would otherwise leave.

Before you enroll — or before you leave — ask:

  1. Is payment made per visit, per milestone, or at the end?
  2. If I leave early, what will I still receive, and when?
  3. Will I be paid for an early termination or final safety visit?
  4. Are travel or parking costs reimbursed even if I do not finish?

Every study is different, and compensation is never guaranteed, so get the answers in writing as part of your consent documents.

When the study team asks you to leave

Sometimes it works the other way. A study doctor may end your participation even if you want to continue. This can happen if:

  • A test result or health change makes continuing unsafe for you
  • You no longer meet the eligibility requirements
  • You become pregnant during a study that does not allow it
  • You are unable to follow the study's requirements, such as attending visits or avoiding certain medications
  • The sponsor stops the entire study, sometimes for safety reasons and sometimes for business or scientific reasons

Being withdrawn by the team is not a punishment. It is usually a protective step. The team should explain why and help you transition back to your usual care.

Can you rejoin later?

Usually not the same study, though it depends on the study design. However, leaving one study rarely prevents you from joining a different one in the future. Some research sites keep track of past participation and may ask about it during screening. Be honest — this helps keep you safe, especially if you took an experimental medication recently.

Leaving a study the right way: a quick checklist

  • Contact the study team as soon as you decide, ideally before stopping any study medication.
  • Ask whether you need to taper off any medication.
  • Ask about an optional final safety visit.
  • Return any study devices, supplies, or unused medication as instructed.
  • Ask what will happen to your data and samples.
  • Confirm what compensation you will receive and when.
  • Let your regular doctor know you have left the study, and share any relevant results the team provides.

The bottom line

Joining a study is a choice you make — and so is staying in one. You can leave whenever you need to. Telling the study team first helps protect your health, settles any questions about compensation, and makes the transition back to your usual care smoother.

If you ever feel pressured to stay, you can contact the Institutional Review Board (IRB) listed on your consent form. They oversee participant protections and can help.

*This article is for general information only and is not medical or legal advice. Always talk with the study team and your own health care provider before making changes to your care.*

This article is general information, not medical advice. Compensation varies by study and is never guaranteed. Read our medical disclaimer.

Looking for a paid study?

Browse currently enrolling studies and see what's available near you.

Browse studies